Bill of Health
DECEMBER 12, 2023
By Tara Davis and Nicola Soekoe In January 2021, the Director General of the World Health Organization (WHO) observed that the world was on the brink of a “catastrophic moral failure” if wealthier nations did not ensure the equitable distribution of COVID-19 vaccines. Impact of the judgment: what have records disclosed shown?
Bill of Health
AUGUST 29, 2022
Like the Open COVID Pledge before it, Moderna’s pledge expressly states that it is valid only “ while the pandemic continues. government purchased millions of doses of Moderna’s mRNA vaccine, along with large quantities of vaccines manufactured by Pfizer. Pfizer made such a vaccine. From 2020 to 2022, the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bill of Health
SEPTEMBER 28, 2023
Despite having an outsized role in the discovery, development, manufacturing, and procurement of COVID-19 vaccines, therapeutics, and diagnostics, the federal government has generally not exercised any leverage in ensuring fair pricing and affordable access to these essential medical products.
HIT Consultant
FEBRUARY 3, 2023
JP Perez-Etchegoyen, CTO of Onapsis Due to the recent growth of the pharmaceutical industry, the value of highly-sensitive data stored in pharmaceutical systems and the degree of the potential damage that cyberattacks on the industry can cause, it is safe to say that pharma could be one of the most targeted industries by cybercriminals in 2023.
Bill of Health
OCTOBER 26, 2023
By noting that non-state actors, such as the pharmaceutical industry, have a “duty to respect human rights in the context of a public health emergency,” the Principles acknowledge the outsized power of non-state actors in global health, and the ways in which they undermine solidarity in the face of a global health emergency.
HIT Consultant
AUGUST 18, 2021
The pandemic has given rise to new norms in drug development that will influence the future of the industry as we know it. The world has been in urgent need of COVID-19 vaccines, treatments, and diagnostic tools. Ronan Brown, SVP and Head of Integrated Global Compliance, IQVIA.
HIT Consultant
MAY 2, 2022
The FDA is attempting to address this, having issued guidelines related to diversity in clinical trials in November 2020 – perhaps prompted by widespread media coverage of the fact that the black members of the society and other people of color were underrepresented in clinical trials for COVID-19 vaccines.
Expert insights. Personalized for you.
144 
Let's personalize your content